Glucocorticoid-induced diabetes mellitus is a risk for vertebral fracture during glucocorticoid treatment

Diabetes Research and Clinical Practice

Volumn 93, Issue 1, 2011, Pages

  Tatsuno, Ichiro ^a,b   Sugiyama, Takao ^c  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

^c SHIMOSHIZU HOSPITAL   (Japan)

Author keywords

Diabetes mellitusl; Fracture; Glucocorticoids; Osteoporosis

Indexed keywords

PREDNISONE;

ADULT; ARTICLE; COLLAGEN DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SAFETY; DRUG USE; EARLY INTERVENTION; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RISK FACTOR; VASCULAR DISEASE; VERTEBRA FRACTURE;

ADULT; AGED; COHORT STUDIES; DIABETES MELLITUS; FEMALE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; SPINAL FRACTURES;

EID: 79960561558     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.03.005     Document Type: Article

References (11)

1. Cushing H. The basophilic adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 1932, 1:137-192.
2. Canalis E., Mazziotti G., Giustina A., Bilezikian J.P. Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 2007, 18:1319-1328.
3. Clore J.N., Thurby-Hay L. Glucocorticoid-induced hyperglycemia. Endocr Pract 2009, 15:469-474.
4. Hofbauer L.C., Brueck C.C., Singh S.K., Dobnig H. Osteoporosis in patients with diabetes mellitus. J Bone Miner Res 2007, 22:1317-1328.
5. Sugiyama T., Suzuki S., Yoshida T., Suyama K., Tanaka T., Sueishi M., et al. Incidence of symptomatic vertebral fractures in women of child-bearing age newly treated with high-dose glucocorticoid. Gen Med 2010, 7:218-229.
6. Tatsuno I., Sugiyama T., Suzuki S., Yoshida T., Tanaka T., Sueishi M., et al. Age-dependent early complication of symptomatic vertebral fracture with high-dose glucocorticoid in treatment for collagen vascular diseases. J Clin Endocrinol Metab 2009, 94:1671-1677.
7. Tatsuno I., Suzuki S., Yoshida T., Tanaka T., Sueishi M., Sugiyama T. High prevalence and early complication of symptomatic vertebral fracture in the elderly treated with high-dose glucocorticoids. J Am Geriatr Soc 2009, 57:188-189.
8. Cervera R., Khamashta M.A., Font J., Sebastiani G.D., Gil A., Lavilla P., et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003, 82:299-308.
9. Langford C.A. Chronic immunosuppressive therapy for systemic vasculitis. Curr Opin Rheumatol 1997, 9:41-47.
10. Nagai S., Izumi T Immunopathology of collagen vascular disease. Curr Opin Pulm Med 1997, 3:356-360.
11. Uzu T., Harada T., Sakaguchi M., Kanasaki M., Isshiki K., Araki S., et al. Glucocorticoid-induced diabetes mellitus: prevalence and risk factors in primary renal diseases. Nephron Clin Pract 2007, 105:c54-57.